Learn More
Tocris Bioscience™ ESI 09 
Epac inhibitor
Manufacturer: Tocris Bioscience™ 4773/50
Description
EPAC inhibitor. Inhibits EPAC-mediated insulin releases from pancreatic β cells. Selective for EPAC over PKA. Decreases migration and invasion of AsPc-1 and PANC-1 pancreatic cancer cells in vitro.This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.
Specifications
| EPAC Inhibitors | |
| C16H15ClN4O2 | |
| α-[(2-(3-Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-3-isoxazolepropanenitrile | |
| Soluble to 100mM in DMSO and to 20mM in ethanol | |
| Bioactive Small Molecules |
| 263707-16-0 | |
| 330.77 | |
| 50mg | |
| Solid | |
| >98% |
Safety and Handling
Recommended Storage : Store at +4°C.
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Research Use Only. Not For Human or Veterinary Use